Amia Capital LLP Black Diamond Therapeutics, Inc. Transaction History
Amia Capital LLP
- $126 Million
- Q3 2023
Shares
3 transactions
Others Institutions Holding BDTX
# of Institutions
93Shares Held
36.5MCall Options Held
29.6KPut Options Held
5K-
Bellevue Group Ag Kuesnacht, V88.52MShares$49 Million0.68% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$38.7 Million0.02% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$25.6 Million1.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.91MShares$11 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.6MShares$9.22 Million0.99% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $209M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...